Patterns of Progression in Hormone Receptor-Positive Metastatic Breast Cancer: An Argument for Local Therapy

被引：0
|
作者：
Rineer, J. M. [1 ]
Dvorak, T. [1 ]
Buchholz, D. [1 ]
Shah, N. [1 ]
Moroose, R. [1 ]
Kelly, P. [1 ]
机构：
[1] UF Hlth Canc Ctr Orlando Hlth, Orlando, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2145
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [31] Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy
    Mariya Rozenblit
    Sophia Mun
    Pamela Soulos
    Kerin Adelson
    Lajos Pusztai
    Sarah Mougalian
    [J]. Breast Cancer Research, 23
  • [32] Locoregional Therapy Patterns in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
    Nguyen, Kenny
    Hersh, Eliza H.
    Chen, Yu-Jen
    King, Tari
    Mittendorf, Elizabeth
    Minami, Christina A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S87 - S88
  • [33] The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
    Bielo, Luca Boscolo
    Trapani, Dario
    Nicolo, Eleonora
    Valenza, Carmine
    Guidi, Lorenzo
    Belli, Carmen
    Kotteas, Elias
    Marra, Antonio
    Prat, Aleix
    Fusco, Nicola
    Criscitiello, Carmen
    Burstein, Harold J.
    Curigliano, Giuseppe
    [J]. CANCER TREATMENT REVIEWS, 2024, 128
  • [34] Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer
    Wilkie, Jonathan
    Schickli, M. Alexandra
    Berger, Michael J.
    Lustberg, Maryam
    Reinbolt, Raquel
    Noonan, Anne
    Ramaswamy, Bhuvaneswari
    Sardesai, Sagar
    VanDeusen, Jeffrey
    Wesolowski, Robert
    Williams, Nicole
    Stover, Daniel G.
    Li, Junan
    Vargo, Craig A.
    [J]. CLINICAL BREAST CANCER, 2020, 20 (01) : 33 - 40
  • [35] When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
    Seidman, Andrew D.
    [J]. ONCOLOGY-NEW YORK, 2016, 30 (03): : 224 - 228
  • [36] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ahrong Ham
    Min Hwan Kim
    Gun Min Kim
    Jee Hung Kim
    Jee Ye Kim
    Hyung Seok Park
    Seho Park
    Young Up Cho
    Byeong Woo Park
    Seung Il Kim
    Joohyuk Sohn
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 107 - 116
  • [37] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer
    Wander, Seth A.
    Spring, Laura M.
    Bardia, Aditya
    [J]. LANCET ONCOLOGY, 2019, 20 (06): : 746 - 748
  • [39] Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
    Lin, Mingxi
    Jin, Yizi
    Yang, Ziyi
    Hu, Xichun
    Zhang, Jian
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [40] Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.
    Leitzel, Kim
    Ali, Suhail M.
    Vasekar, Monali K.
    Nagabhairu, Vinod
    Marks, Eric
    Ali, Ayesha
    Krecko, Laura
    Willumsen, Nicholas
    Leeming, Diana Julie
    Karsdal, Morten Asser
    Lipton, Allan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345